Reasons Why You Should Invest in Genpact Limited Stock Now
Werte in diesem Artikel
Genpact Limited G is a well-performing stock, with a significant price rise over the past six months and strong fundamentals. Therefore, if you haven’t taken advantage of the price appreciation yet, it’s time you added the stock to your portfolio, as we believe that it has the potential to carry the momentum in the near term.Why is Genpact an Attractive Pick?Share Price Appreciation: A glance at the company’s price trend reveals that the stock has had an impressive run over the past six months. G has returned 31%, which compared favorably with the industry's 17% rally and the Zacks S&P 500 composite’s 3.5% rise.Genpact Limited Price Genpact Limited price | Genpact Limited QuoteSolid Rank & VGM Score: Genpact currently carries a Zacks Rank #2 (Buy) and has a VGM Score of B. Our research shows that stocks with a VGM Score of A or B, combined with a Zacks Rank #1 (Strong Buy) or 2, offer the best investment opportunities for investors. Thus, the company appears to be a compelling investment proposition at the moment.Positive Earnings Surprise History: Genpact has an impressive earnings surprise history. The company outpaced the Zacks Consensus Estimate in each of the trailing four quarters, delivering a positive average earnings surprise of 7.8%.Strong Growth Prospects: The Zacks Consensus Estimate for the company’s 2024 earnings of $3.23 indicates year-over-year growth of 8.4%. Earnings are expected to register 6.6% growth in 2025. The stock has a long-term expected earnings per share growth rate of 9.8%.Growth Drivers: Genpact is a prominent BPO services provider, excelling in business analytics, digital, and consulting solutions. Its domain expertise spans Industrial IoT, supply chain management, digital content, and AI-driven services, supporting consistent revenue growth at a 5% CAGR from 2019 to 2023. We expect a 6.6% revenue increase in 2024, driven by innovative offerings like Digital Smart Enterprise Processes (SEPs) and the AI-powered Genpact Cora platform, enhancing efficiency and digital transformation for clients.Committed to shareholder value, Genpact has steadily increased dividends, with payouts reaching $100 million in 2023, alongside significant share repurchases. Its robust liquidity is backed by a $1 billion cash balance against $426 million in current debt, maintaining a strong current ratio of 1.85, well above the industry average. This financial strength positions Genpact to capitalize on AI advancements while ensuring operational stability and sustained returns for investors.Other Stocks to ConsiderSome other top-ranked stocks from the broader Zacks Business Services sector are Fiserv FI and Paychex PAYX, each carrying a Zacks Rank of 2 at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Fiserv has a long-term earnings growth expectation of 14.9%. FI delivered a trailing four-quarter earnings surprise of 3.1%, on average.Paychex has a long-term earnings growth expectation of 7.3%. PAYX delivered a trailing four-quarter earnings surprise of 1.7%, on average.Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Paychex, Inc. (PAYX): Free Stock Analysis Report Genpact Limited (G): Free Stock Analysis Report Fiserv, Inc. (FI): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Genpact
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Genpact
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Genpact LtdShs
Analysen zu Genpact LtdShs
Datum | Rating | Analyst | |
---|---|---|---|
08.08.2019 | Genpact Buy | Needham & Company, LLC | |
14.06.2019 | Genpact Buy | Needham & Company, LLC | |
04.08.2017 | Genpact Market Perform | BMO Capital Markets | |
04.08.2017 | Genpact Neutral | Wedbush Morgan Securities Inc. | |
11.04.2016 | Genpact Underperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
08.08.2019 | Genpact Buy | Needham & Company, LLC | |
14.06.2019 | Genpact Buy | Needham & Company, LLC | |
04.08.2017 | Genpact Market Perform | BMO Capital Markets | |
29.08.2011 | Genpact outperform | Oppenheimer & Co. Inc. | |
19.05.2011 | Genpact outperform | Oppenheimer & Co. Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
04.08.2017 | Genpact Neutral | Wedbush Morgan Securities Inc. | |
02.03.2015 | Genpact Hold | Deutsche Bank AG | |
05.02.2015 | Genpact Hold | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
11.04.2016 | Genpact Underperform | RBC Capital Markets | |
30.07.2010 | Genpact sell | Kaufman Bros., LP |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Genpact LtdShs nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen